MyoPax

News

Bayer's network of Co.Lab life sciences incubators has expanded once again with the official opening of a site in Berlin, its first in Europe

News

Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.